Thank you very much for that comprehensive list of questions. Let me just say generally that, first of all, we do have an ongoing discussion with my provincial and territorial counterparts on the national pharmaceuticals strategy element of the 2004 health accord, and I dare say that at our next federal-provincial-territorial meeting in December it will be a topic of conversation. Certainly, what I've laid out to the provinces is that I think there are ways we can work together that will save money for the drug benefit plans in some areas, which then can be reallocated for catastrophic drugs and for expensive drugs for rare diseases, so there is a way to make this self-sustaining and possible.
Whereas our means may be different, our end may be the same.